Fish oil is one of Canada's most popular supplements — and one of the more plausible candidates for modest bone benefit, given that omega-3 fatty acids reduce inflammatory cytokines that drive bone resorption. But the evidence is more nuanced than the marketing. Here's what's actually established, what's promising, and how omega-3s fit (or don't) into a serious bone health plan.
Bone turnover is partly regulated by inflammatory pathways. Osteoclast activity — the bone-breakdown side of the equation — is stimulated by pro-inflammatory cytokines, particularly TNF-α, IL-1, and IL-6. These are the same cytokines elevated in chronic inflammatory conditions like rheumatoid arthritis, where bone loss is a known complication.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the long-chain omega-3 fatty acids from fish and fish oil, suppress production of these pro-inflammatory cytokines and their precursor prostaglandin PGE2. The hypothesis: by dampening chronic low-grade inflammation, omega-3s create a less hostile environment for bone formation and preservation.
There are also direct cellular mechanisms under investigation. Animal studies show DHA promotes osteoblast differentiation (bone-building cells) and inhibits osteoclast formation. DHA also improves calcium absorption in the gut by modifying membrane fluidity in intestinal cells. These mechanisms are plausible but human evidence hasn't yet confirmed the magnitude of the clinical effect.
Multiple large observational studies have found associations between higher omega-3 intake (from food or supplements) and better bone mineral density:
The RCT evidence is less consistent than observational data, which is typical of dietary supplement research:
Omega-6 fatty acids (primarily linoleic acid, abundant in vegetable oils) are also essential but compete with omega-3s in biological pathways. High omega-6 intake relative to omega-3 promotes inflammatory eicosanoid production. The typical Canadian diet has an omega-6:omega-3 ratio of approximately 15:1 to 20:1 — far from the 4:1 or lower ratio associated with lower inflammatory burden in populations with good bone health outcomes.
This matters practically: reducing processed food consumption (high in omega-6 vegetable oils) while increasing omega-3-rich foods has a different and potentially larger impact on the inflammatory-to-bone pathway than supplementation alone. Adding fish oil on top of a high-omega-6 diet is a partial solution.
| Food | Serving | EPA+DHA (approx.) | Bonus Bone Nutrients |
|---|---|---|---|
| Atlantic salmon (wild or farmed) | 100g cooked | 1,800–2,200mg | Vitamin D, protein |
| Canned sardines (with bones) | 85g | 1,100–1,400mg | Calcium (~350mg), vitamin D |
| Canned pink salmon (with bones) | 85g | 1,000–1,200mg | Calcium (~240mg), vitamin D |
| Mackerel (Atlantic) | 100g cooked | 2,200–2,600mg | Vitamin D, selenium |
| Rainbow trout | 100g cooked | 900–1,200mg | Vitamin D, protein |
| Herring | 100g cooked | 1,700–2,000mg | Vitamin D, calcium |
| Flaxseed (ground) | 2 tbsp | ~2,400mg ALA (not EPA/DHA) | Limited EPA/DHA conversion |
| Chia seeds | 2 tbsp | ~4,000mg ALA | Calcium (~180mg) |
A key note on plant-based omega-3s: flaxseed and chia seeds contain alpha-linolenic acid (ALA), which the body can convert to EPA and DHA — but conversion efficiency is low (typically 5–10% for EPA, less for DHA). Plant-based omega-3s from flax and chia are beneficial overall, but they are not equivalent to marine EPA/DHA for inflammatory pathway modulation.
For vegan Canadians, algal oil supplements (derived from marine algae — the original source that fish accumulate EPA/DHA from) provide EPA and DHA directly without animal products.
Canned sardines with bones deserve special mention in the context of bone health. They provide omega-3s AND calcium in a highly bioavailable form — the soft bones in canned sardines are an excellent calcium source at approximately 350mg per 85g serving. This is one of the few foods that simultaneously addresses both the anti-inflammatory (omega-3) and calcium-supply sides of the bone health equation.
Canadian canned sardines (available at Costco, major grocery chains) are affordable — typically $2–5 per can — and a twice-weekly habit of sardines on toast or crackers contributes meaningfully to both omega-3 and calcium targets. See the calcium-rich foods guide for the full picture of non-dairy calcium sources.
Most research on bone effects has used 1,000–3,000mg of combined EPA+DHA per day. Standard fish oil capsules typically contain 180mg EPA + 120mg DHA per 1,000mg capsule — meaning 300mg of combined omega-3s per capsule. To reach 1,000mg EPA+DHA, you'd need approximately 3–4 standard capsules.
High-concentration formulations (e.g., 60–70% omega-3 concentration) allow reaching target doses with fewer capsules and less fish oil "burp" — a common compliance barrier. Triglyceride form fish oil is better absorbed than ethyl ester form, though usually more expensive.
Fish oil oxidizes easily. Rancid fish oil not only tastes unpleasant but may negate benefits by introducing oxidative stress. Quality indicators:
Fish oil supplements are available widely at Shoppers Drug Mart, Rexall, London Drugs, and health food stores like Whole Foods. Costco carries large-format fish oil at competitive prices. Typical Canadian pricing: $25–60 for a 2–3 month supply of quality fish oil at a bone-relevant dose. Fish oil is not covered by any provincial drug plan but is an eligible expense under many extended health benefits' "natural health products" or "vitamins/supplements" categories.
The anti-inflammatory benefit of omega-3s is most clinically relevant in specific contexts where inflammation is driving bone loss:
Omega-3 supplementation is not a replacement for the core evidence-based interventions for bone health. It sits in the "additional support" category:
| Intervention | Evidence Strength for Bone | Effect Magnitude |
|---|---|---|
| Bisphosphonate therapy | Very strong (RCT) | Large (40–50% fracture reduction) |
| Resistance training | Strong (RCT + observational) | Moderate (2–8% BMD gain) |
| Calcium + Vitamin D | Strong (RCT) | Moderate (prevention of deficiency-related loss) |
| Adequate protein intake | Moderate | Small-moderate |
| Omega-3 fatty acids | Moderate (inconsistent RCTs) | Small (0.5–2% BMD, fracture data limited) |
| Collagen peptides | Limited | Small (emerging evidence) |
For someone already doing the fundamentals well — adequate calcium, vitamin D, protein, and resistance exercise — adding 1–2g/day of EPA+DHA is a low-risk, potentially beneficial addition. The anti-inflammatory benefits extend beyond bone (cardiovascular, joint health, cognitive) making it a reasonable general health choice even where bone-specific evidence is modest.